Clarke, Stephen

Clingan, Phillip R

De Boer, Richard

Johnston, Michael

Michael, M. G.

Pavlakis, Nick

English

Research Online

University of Wollongong Research Online Faculty of Science - Papers (Archive) Faculty of Science, Medicine and Health 1-1-2009 A multi-centre randomized, open-label phase II trial of erlotinib plus gemcitabine or gemcitabine monotherapy as first-line therapy in ECOG PS2 patients with chemo-naive advanced NSCLC M. G. Michael University of Wollongong, mgm@uow.edu.au Michael Johnston Roche Prod Pty Ltd Stephen Clarke Richard De Boer Royal Melbourne Hospital Phillip R. Clingan University of Wollongong, philipc@uow.edu.au See next page for additional authors Follow this and additional works at: https://ro.uow.edu.au/scipapers  Part of the Life Sciences Commons, Physical Sciences and Mathematics Commons, and the Social and Behavioral Sciences Commons Recommended Citation Michael, M. G.; Johnston, Michael; Clarke, Stephen; De Boer, Richard; Clingan, Phillip R.; and Pavlakis, Nick: A multi-centre randomized, open-label phase II trial of erlotinib plus gemcitabine or gemcitabine monotherapy as first-line therapy in ECOG PS2 patients with chemo-naive advanced NSCLC 2009. https://ro.uow.edu.au/scipapers/331 Research Online is the open access institutional repository for the University of Wollongong. For further information contact the UOW Library: research-pubs@uow.edu.au A multi-centre randomized, open-label phase II trial of erlotinib plus gemcitabine or gemcitabine monotherapy as first-line therapy in ECOG PS2 patients with chemo-naive advanced NSCLC Keywords randomized, centre, multi, naive, chemo, patients, ps2, ecog, therapy, line, first, monotherapy, gemcitabine, plus, erlotinib, trial, nsclc, ii, advanced, phase, label, open Disciplines Life Sciences | Physical Sciences and Mathematics | Social and Behavioral Sciences Authors M. G. Michael, Michael Johnston, Stephen Clarke, Richard De Boer, Phillip R. Clingan, and Nick Pavlakis This journal article is available at Research Online: https://ro.uow.edu.au/scipapers/331 

A multi-centre randomized, open-label phase II trial of erlotinib plus gemcitabine or gemcitabine monotherapy as first-line therapy in ECOG PS2 patients with chemo-naive advanced NSCLC

https://ro.uow.edu.au/cgi/viewcontent.cgi?article=1365&context=scipapers

A multi-centre randomized, open-label phase II trial of erlotinib plus gemcitabine or gemcitabine monotherapy as first-line therapy in ECOG PS2 patients with chemo-naive advanced NSCLC

Abstract

Similar works

Full text

Available Versions

Research Online